塞诺巴马特是一种新型有前途的抗发作药物:实验和临床方面
Barbara Błaszczyk1, Stanisław J Czuczwar2, Barbara Miziak2
1Faculty of Medical Sciences, Lipinski University, 25-734 Kielce, Poland.
International journal of molecular sciences
|December 17, 2024
概括
塞诺巴为耐药性提供了一个新的治疗选择,通过抑制电流和增强GABAergic活性,有效减少发作. 临床试验显示,发作显著减少,副作用与现有的抗药物相比较.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐药性影响40-50%的患者,限制了治疗选择.
- 现有的抗发作药物 (ASM) 在大量患者群体中有效性有限.
研究的目的:
- 评估赛诺巴酸作为焦点发作的补充治疗的疗效和安全性.
- 探索塞诺巴酸盐的作用机制和神经保护潜力.
主要方法:
- 对临床前发作模型和随机临床试验的审查.
- 对塞诺巴酸对持续流和GABA介导事件的影响的分析.
- 在临床研究中减少发作频率和不良事件的评估.
主要成果:
- 塞诺巴在多个实验性发作模型中表现出有效性.
- 临床试验显示,当作为附加疗法使用时,显著减少了发作和无发作患者的百分比.
- 与塞诺巴酸相关的不良事件与其他ASM相似.
结论:
- 塞诺巴马特为耐药焦点提供了一个有前途的治疗选择.
- 它的双重作用机制 (减少兴奋,增强抑制) 促使其抗发作潜力.
- 塞诺巴的神经保护性质可能会影响发育,可能会改变的进展.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
143
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
143
Antiepileptic Drugs: Calcium Channel Blockers
313
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
313
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
245
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
245
Antiepileptic Drugs: Glutamate Antagonists
280
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
280
Antiepileptic Drugs: GABAergic Pathway Potentiators
325
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
325
Antiepileptic Drugs: Sodium Channel Blockers
410
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
410


